FDA Approved: CUVRIOR — Original Application (Orphalan SA)

View source ↗

Summary

FDA approves CUVRIOR (trientine tetrahydrochloride) under an original New Drug Application from Orphalan SA for Wilson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• CUVRIOR (trientine tetrahydrochloride)

Snippet

ORIG AP for CUVRIOR (TRIENTINE TETRAHYDROCHLORIDE)